@article{nano_rtpa_insilico_2025,
  title={Machine Learning-Enhanced In-Silico Evaluation of Nano-rtPA for Acute Ischemic Stroke: Integrating Mechanistic Modeling, External Validation, and Personalized Medicine},
  author={[Author Names]},
  journal={[Target Journal]},
  year={2025},
  volume={[Volume]},
  pages={[Pages]},
  doi={[DOI]},
  keywords={acute ischemic stroke, nanoparticles, rtPA, in-silico modeling, machine learning, Bayesian neural networks, Gaussian processes, causal inference},
  abstract={Background: Nanoparticle-encapsulated recombinant tissue plasminogen activator (Nano-rtPA) promises enhanced thrombolytic efficacy with improved safety. Methods: We developed a comprehensive in-silico platform integrating mechanistic ODE modeling, external validation (NIHSS_802 N=802, IST N=19,435), virtual RCT (N=1,000), and machine learning (Bayesian Neural Networks, Gaussian Process Regression, Causal Forest). Results: Nano-rtPA demonstrated 28% relative improvement in good outcomes (RR=1.28, 95% CI [1.01, 1.77], P(superiority)=98.5%), 30% sICH reduction, 59% dose reduction potential, and 3.5Ã— benefit in optimal subgroups (younger patients, early treatment). Probabilistic sensitivity analysis confirmed robustness (95% CI [1.01, 1.77]). Conclusions: Nano-rtPA shows promising efficacy and safety profile warranting Phase III clinical investigation.}
}

@misc{nano_rtpa_github_2025,
  author={[Author Names]},
  title={Nano-rtPA In-Silico Platform: Complete Code Repository},
  year={2025},
  publisher={GitHub},
  howpublished={\url{https://github.com/yourusername/nano-rtpa-insilico-repo}},
  note={Accessed: [Date]}
}
